Morgan Stanley Deciphera Pharmaceuticals, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Oct 17, 2024	BUY	$13.58 - $17.36 $20.9 Million - $26.7 Million	1,539,826 New	1,539,826 $24.2 Million
Q1 2024 Aug 16, 2024	SELL	$13.58 - $17.36 $10.5 Million - $13.5 Million	-776,607 Reduced 33.53%	1,539,826 $24.2 Million
Q1 2024 May 15, 2024	SELL	$13.58 - $17.36 $10.5 Million - $13.5 Million	-776,607 Reduced 33.53%	1,539,826 $24.2 Million
Q4 2023 Aug 16, 2024	BUY	$10.11 - $16.54 $23.4 Million - $38.3 Million	2,316,433 New	2,316,433 $37.4 Million
Q4 2023 Feb 13, 2024	BUY	$10.11 - $16.54 $7.31 Million - $12 Million	723,448 Added 45.41%	2,316,433 $37.4 Million
Q3 2023 Nov 15, 2023	BUY	$12.46 - $15.48 $2.77 Million - $3.44 Million	222,276 Added 16.22%	1,592,985 $20.3 Million
Q2 2023 Aug 14, 2023	BUY	$13.28 - $15.96 $5.8 Million - $6.97 Million	436,913 Added 46.79%	1,370,709 $19.3 Million
Q1 2023 May 15, 2023	BUY	$14.26 - $22.1 $4.63 Million - $7.17 Million	324,538 Added 53.27%	933,796 $14.4 Million
Q4 2022 Feb 14, 2023	BUY	$14.85 - $19.04 $112,191 - $143,847	7,555 Added 1.26%	609,258 $9.99 Million
Q3 2022 Nov 14, 2022	SELL	$12.38 - $20.23 $3.78 Million - $6.18 Million	-305,493 Reduced 33.67%	601,703 $11.1 Million
Q2 2022 Oct 27, 2022	BUY	$9.11 - $13.98 $1.95 Million - $3 Million	214,572 Added 30.98%	907,196 $11.9 Million
Q2 2022 Aug 15, 2022	BUY	$9.11 - $13.98 $1.95 Million - $3 Million	214,572 Added 30.98%	907,196 $11.9 Million
Q1 2022 Oct 27, 2022	SELL	$6.87 - $11.11 $1.47 Million - $2.38 Million	-214,572 Reduced 23.65%	692,624 $6.42 Million
Q1 2022 May 13, 2022	BUY	$6.87 - $11.11 $3.16 Million - $5.11 Million	459,504 Added 197.11%	692,624 $6.42 Million
Q4 2021 Feb 14, 2022	BUY	$7.7 - $37.13 $1.43 Million - $6.91 Million	186,189 Added 396.73%	233,120 $2.28 Million
Q3 2021 Nov 15, 2021	BUY	$26.46 - $37.15 $1.24 Million - $1.74 Million	46,931 New	46,931 $1.59 Million

Others Institutions Holding DCPH

# of Institutions

Shares Held

293K

Call Options Held

500

Put Options Held

View Full List

About Deciphera Pharmaceuticals, Inc.

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

More about DCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account